跳至主要内容
临床试验/EUCTR2011-005522-22-FI
EUCTR2011-005522-22-FI进行中(未招募)不适用

The effects of PXR activation on blood pressure regulation - Rifa-BP

Oulu University Hospital, Department of Internal Medicine0 个研究点开始时间: 2012年1月9日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • oHealthy volunteers
  • o18-40 years of age
  • oBody mass index (BMI) 19-30 kg/m2
  • oSystolic blood pressure 95–140 mmHg
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 22
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • oDiastolic blood pressure over 90 mmHg
  • oAny continuous medication (hormonal intrauterine device is permitted)
  • oAny significant medical condition
  • oInsensitivity to rifampicin
  • oPregnancy and lactation
  • oPrevious difficult venipuncture
  • oAlcohol and medicine abuse and drug use
  • oParticipation to any other pharmaceutical trial within on month of screening

研究者

发起方
Oulu University Hospital, Department of Internal Medicine

相似试验